{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:19:32Z","timestamp":1759483172465},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.bone.2009.03.663","type":"journal-article","created":{"date-parts":[[2009,3,30]],"date-time":"2009-03-30T22:24:48Z","timestamp":1238451888000},"page":"S19-S25","source":"Crossref","is-referenced-by-count":14,"special_numbering":"S1","title":["Usefulness of bone resorption markers in hemodialysis patients"],"prefix":"10.1016","volume":"45","author":[{"given":"Takayuki","family":"Hamano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kodo","family":"Tomida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiko","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enyu","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Rakugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Isaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2009.03.663_bib1","doi-asserted-by":"crossref","unstructured":"National Kidney Foundation:K\/DOQI Clinical Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis 2003;42 (suppl. 3):S1\u2013S202;","DOI":"10.1016\/S0272-6386(03)00905-3"},{"issue":"6","key":"10.1016\/j.bone.2009.03.663_bib2","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1046\/j.1523-1755.1999.00461.x","article-title":"Circulating biochemical markers of bone remodeling in uremic patients","volume":"55","author":"Ure\u00f1a","year":"1999","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2009.03.663_bib3","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.lfs.2005.02.007","article-title":"Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH","volume":"77","author":"Ueda","year":"2005","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.bone.2009.03.663_bib4","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1681\/ASN.V73506","article-title":"Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients","volume":"7","author":"Ure\u00f1a","year":"1996","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.bone.2009.03.663_bib5","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/ki.2008.248","article-title":"High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death","volume":"74","author":"Blayney","year":"2008","journal-title":"Kidney Int."},{"issue":"11","key":"10.1016\/j.bone.2009.03.663_bib6","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1681\/ASN.2008010014","article-title":"Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients","volume":"19","author":"Regidor","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"issue":"12","key":"10.1016\/j.bone.2009.03.663_bib7","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1373\/clinchem.2005.051524","article-title":"Serum concentrations of cross-linked N-telopeptides of type I collagen: new marker for bone resorption in hemodialysis patients","volume":"51","author":"Maeno","year":"2005","journal-title":"Clin Chem."},{"key":"10.1016\/j.bone.2009.03.663_bib8","article-title":"Bone markers for non-invasive diagnosis of adynamic bone disease in hemodialysis patients","volume":"19: 4A","author":"Asci","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.bone.2009.03.663_bib9","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.bone.2006.04.022","article-title":"Serum NTX is a practical marker for assessing antiresorptive therapy for glucocorticoid treated patients with chronic kidney disease","volume":"39","author":"Hamano","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.bone.2009.03.663_bib10","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1359\/jbmr.2000.15.7.1337","article-title":"Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption","volume":"15","author":"Halleen","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2009.03.663_bib11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1242\/jcs.113.3.377","article-title":"The cell biology of osteoclast function","volume":"113","author":"V\u00e4\u00e4n\u00e4nen","year":"2000","journal-title":"J. Cell Sci."},{"issue":"2","key":"10.1016\/j.bone.2009.03.663_bib12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2265.2008.03187.x","article-title":"Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction","volume":"69","author":"Yamada","year":"2008","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"5","key":"10.1016\/j.bone.2009.03.663_bib13","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/S0272-6386(03)00203-8","article-title":"Correlation between histomorphometric parameters of bone resorption and serum type 5b tartrate-resistant acid phosphatase in uremic patients on maintenance hemodialysis","volume":"41","author":"Chu","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bone.2009.03.663_bib14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cca.2006.08.021","article-title":"Nomura F Development of a novel fragments absorbed immunocapture enzyme assay system for tartrateresistant acid phosphatase 5b","volume":"376","author":"Ohashi","year":"2007","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bone.2009.03.663_bib15","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/bmj.4.5893.643","article-title":"Interpretation of serum calcium in patients with abnormal serum proteins","volume":"4","author":"Payne","year":"1973","journal-title":"Br. Med. J."},{"issue":"7","key":"10.1016\/j.bone.2009.03.663_bib16","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/BF00311432","article-title":"Evaluation of bone loss and the serum markers of bone metabolism in patients with hyperparathyroidism","volume":"25","author":"Katagiri","year":"1995","journal-title":"Surg. Today"},{"issue":"11","key":"10.1016\/j.bone.2009.03.663_bib17","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s001980170026","article-title":"Estimation of bone mineral density by digital X-ray radiogrammetry: theoretical background and clinical testing","volume":"12","author":"Rosholm","year":"2001","journal-title":"Osteoporos Int."},{"issue":"5","key":"10.1016\/j.bone.2009.03.663_bib18","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.bone.2005.02.008","article-title":"Impact of lowering dialysate calcium concentration on serum bone turnover markers in hemodialysis patients","volume":"36","author":"Hamano","year":"2005","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.bone.2009.03.663_bib19","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/ndt\/gfl837","article-title":"Significance of time-course changes of serum bone markers after parathyroidectomy in patients with uraemic hyperparathyroidism","volume":"22","author":"Yajima","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bone.2009.03.663_bib20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0221-8747(84)90065-1","article-title":"Reconstruction of the resorptive site in iliac trabecular bone: a kinetic model for bone resorption in 20 normal individuals","volume":"5","author":"Eriksen","year":"1984","journal-title":"Metab. Bone Dis. Relat. Res."},{"key":"10.1016\/j.bone.2009.03.663_bib21","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0221-8747(84)90066-3","article-title":"Reconstruction of the formative site in iliac trabecular bone in 20 normal individuals employing a kinetic model for matrix and mineral apposition","volume":"5","author":"Eriksen","year":"1984","journal-title":"Metab. Bone Dis. Relat. Res."},{"issue":"3","key":"10.1016\/j.bone.2009.03.663_bib22","first-page":"81","article-title":"PICP as bone formation and NTx as bone resorption maker in patients with chronic renal failure","volume":"21","author":"Franke","year":"1998","journal-title":"Eur. J. Med. Res."},{"issue":"3","key":"10.1016\/j.bone.2009.03.663_bib23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00774-007-0826-0","article-title":"Reference intervals of serum tartrate-resistant acid phosphatase type 5b activity measured with a novel assay in Japanese subjects","volume":"26","author":"Nishizawa","year":"2008","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bone.2009.03.663_bib24","first-page":"S104","article-title":"Clinical relevance of cytokine production in hemodialysis","volume":"76","author":"Grandaliano","year":"2000","journal-title":"Kidney Int. Suppl."},{"issue":"6","key":"10.1016\/j.bone.2009.03.663_bib25","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1210\/en.137.6.2217","article-title":"Estrogen blocks parathyroid hormone (PTH)-stimulated osteoclast-like cell formation by selectively affecting PTH-responsive cyclic adenosine monophosphate pathway","volume":"137","author":"Kaji","year":"1996","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.bone.2009.03.663_bib26","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1046\/j.1523-1755.2003.00005.x","article-title":"Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis","volume":"63","author":"Hern\u00e1ndez","year":"2003","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.bone.2009.03.663_bib27","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00223-008-9127-4","article-title":"Serum levels of TRAP5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients","volume":"82","author":"Shidara","year":"2008","journal-title":"Calcif Tissue Int."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328209012150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328209012150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,3]],"date-time":"2021-10-03T19:20:13Z","timestamp":1633288813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328209012150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":27,"alternative-id":["S8756328209012150"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2009.03.663","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}